基于 3 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the detailed record of transactions filed by Chodakewitz Jeffrey. Officer active across 4 companies, notably Vertex Pharmaceuticals INC / MA. Cumulatively, 11 reports have been published. Breakdown: 0 buy · 2 sells. Activity tracked since 1 June 2023. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Chodakewitz Jeffrey is a declarant linked to Schrodinger, Inc., Vertex Pharmaceuticals INC / MA, Adicet Bio, Inc. and Praxis Precision Medicines, Inc., where the stated role is Director for Schrodinger, Inc., Adicet Bio, Inc. and Praxis Precision Medicines, Inc., and EVP GMDA, CMO for Vertex Pharmaceuticals INC / MA. The record shows 9 filings in total, and the recent filings we hold run from 2016-02-04 to 2026-06-23, with attribution entries in recent filings for Schrodinger, Inc., Praxis Precision Medicines, Inc. and Adicet Bio, Inc.